BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1943 related articles for article (PubMed ID: 31944175)

  • 1. Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke: a systematic review and economic evaluation.
    Edwards SJ; Wakefield V; Jhita T; Kew K; Cain P; Marceniuk G
    Health Technol Assess; 2020 Jan; 24(5):1-184. PubMed ID: 31944175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lead-I ECG for detecting atrial fibrillation in patients with an irregular pulse using single time point testing: a systematic review and economic evaluation.
    Duarte R; Stainthorpe A; Greenhalgh J; Richardson M; Nevitt S; Mahon J; Kotas E; Boland A; Thom H; Marshall T; Hall M; Takwoingi Y
    Health Technol Assess; 2020 Jan; 24(3):1-164. PubMed ID: 31933471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid antigen detection and molecular tests for group A streptococcal infections for acute sore throat: systematic reviews and economic evaluation.
    Fraser H; Gallacher D; Achana F; Court R; Taylor-Phillips S; Nduka C; Stinton C; Willans R; Gill P; Mistry H
    Health Technol Assess; 2020 Jun; 24(31):1-232. PubMed ID: 32605705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic tools for identification of high risk in people with Crohn's disease: systematic review and cost-effectiveness study.
    Edwards SJ; Barton S; Bacelar M; Karner C; Cain P; Wakefield V; Marceniuk G
    Health Technol Assess; 2021 Mar; 25(23):1-138. PubMed ID: 33783345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis.
    Sterne JA; Bodalia PN; Bryden PA; Davies PA; López-López JA; Okoli GN; Thom HH; Caldwell DM; Dias S; Eaton D; Higgins JP; Hollingworth W; Salisbury C; Savović J; Sofat R; Stephens-Boal A; Welton NJ; Hingorani AD
    Health Technol Assess; 2017 Mar; 21(9):1-386. PubMed ID: 28279251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of arrhythmia detection in implantable cardiac monitors: A prospective randomized clinical trial comparing Reveal LINQ and Confirm Rx.
    Ip J; Jaffe B; Castellani M; Sheikh A; Castellani C; Ip R
    Pacing Clin Electrophysiol; 2020 Nov; 43(11):1344-1350. PubMed ID: 32969518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of insertable cardiac monitors for the detection of atrial fibrillation in patients with cryptogenic stroke in the United States is cost-effective.
    Maervoet J; Bossers N; Borge RP; Hilpert ST; van Engen A; Smala A
    J Med Econ; 2019 Nov; 22(11):1221-1234. PubMed ID: 31480905
    [No Abstract]   [Full Text] [Related]  

  • 8. Testing strategies for Lynch syndrome in people with endometrial cancer: systematic reviews and economic evaluation.
    Stinton C; Jordan M; Fraser H; Auguste P; Court R; Al-Khudairy L; Madan J; Grammatopoulos D; Taylor-Phillips S
    Health Technol Assess; 2021 Jun; 25(42):1-216. PubMed ID: 34169821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness, utilisation and cost associated with implantable loop recorders versus external monitors after ischaemic or cryptogenic stroke.
    Dhruva SS; Murillo J; Ameli O; Chaisson CE; Redberg RF; Cohen K
    Open Heart; 2024 May; 11(1):. PubMed ID: 38719499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke.
    Diamantopoulos A; Sawyer LM; Lip GY; Witte KK; Reynolds MR; Fauchier L; Thijs V; Brown B; Quiroz Angulo ME; Diener HC
    Int J Stroke; 2016 Apr; 11(3):302-12. PubMed ID: 26763916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF
    Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uncovering Atrial Fibrillation Beyond Short-Term Monitoring in Cryptogenic Stroke Patients: Three-Year Results From the Cryptogenic Stroke and Underlying Atrial Fibrillation Trial.
    Brachmann J; Morillo CA; Sanna T; Di Lazzaro V; Diener HC; Bernstein RA; Rymer M; Ziegler PD; Liu S; Passman RS
    Circ Arrhythm Electrophysiol; 2016 Jan; 9(1):e003333. PubMed ID: 26763225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis.
    Welton NJ; McAleenan A; Thom HH; Davies P; Hollingworth W; Higgins JP; Okoli G; Sterne JA; Feder G; Eaton D; Hingorani A; Fawsitt C; Lobban T; Bryden P; Richards A; Sofat R
    Health Technol Assess; 2017 May; 21(29):1-236. PubMed ID: 28629510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review.
    Lane DA; Raichand S; Moore D; Connock M; Fry-Smith A; Fitzmaurice DA;
    Health Technol Assess; 2013 Jul; 17(30):1-188. PubMed ID: 23880057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme-linked immunosorbent assays for monitoring TNF-alpha inhibitors and antibody levels in people with rheumatoid arthritis: a systematic review and economic evaluation.
    Tikhonova IA; Yang H; Bello S; Salmon A; Robinson S; Hemami MR; Dodman S; Kharechko A; Haigh RC; Jani M; McDonald TJ; Hoyle M
    Health Technol Assess; 2021 Feb; 25(8):1-248. PubMed ID: 33555998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers for assessing acute kidney injury for people who are being considered for admission to critical care: a systematic review and cost-effectiveness analysis.
    Brazzelli M; Aucott L; Aceves-Martins M; Robertson C; Jacobsen E; Imamura M; Poobalan A; Manson P; Scotland G; Kaye C; Sawhney S; Boyers D
    Health Technol Assess; 2022 Jan; 26(7):1-286. PubMed ID: 35115079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term detection of atrial fibrillation with insertable cardiac monitors in a real-world cryptogenic stroke population.
    Ziegler PD; Rogers JD; Ferreira SW; Nichols AJ; Richards M; Koehler JL; Sarkar S
    Int J Cardiol; 2017 Oct; 244():175-179. PubMed ID: 28624331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insertable cardiac monitors: current indications and devices.
    Sakhi R; Theuns DAMJ; Szili-Torok T; Yap SC
    Expert Rev Med Devices; 2019 Jan; 16(1):45-55. PubMed ID: 30522350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-sensitivity troponin assays for early rule-out of acute myocardial infarction in people with acute chest pain: a systematic review and economic evaluation.
    Westwood M; Ramaekers B; Grimm S; Worthy G; Fayter D; Armstrong N; Buksnys T; Ross J; Joore M; Kleijnen J
    Health Technol Assess; 2021 May; 25(33):1-276. PubMed ID: 34061019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical effectiveness and cost-effectiveness of point-of-care tests (CoaguChek system, INRatio2 PT/INR monitor and ProTime Microcoagulation system) for the self-monitoring of the coagulation status of people receiving long-term vitamin K antagonist therapy, compared with standard UK practice: systematic review and economic evaluation.
    Sharma P; Scotland G; Cruickshank M; Tassie E; Fraser C; Burton C; Croal B; Ramsay CR; Brazzelli M
    Health Technol Assess; 2015 Jun; 19(48):1-172. PubMed ID: 26138549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 98.